Article
Testing mutual exclusivity of ETS rearranged prostate cancer
25 Oct 2010
Abstract excerpt
Prostate cancer is a clinically heterogeneous and multifocal disease. More than 80% of patients with prostate cancer harbor multiple geographically discrete cancer foci at the time of diagnosis. Emerging data suggest that these foci are molecularly distinct consistent with the hypothesis that they arise as independent clones. One of the strongest arguments is the heterogeneity observed in the status of E26...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
